Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US5036099A · kind A · utility
11Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 1989 |
| Grant date | Jul 30, 1991 |
| Priority date | — |
| Expiry date | Jul 18, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide having advantageous properties for formulation as an analgesic or antiinflammatory agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.